Schizotypal Personality Disorder

• CLINICAL_TRIALS research · 2025-12-10
  Clinical Trial Update: PS-Trauma - Development of Trauma Treatment for Patients With Co-morbid Psychotic Disorders and Traumas [NA]

  An ongoing PS-Trauma clinical trial aims to develop trauma treatment for patients with co-morbid psychotic disorders, with recruitment ongoi…

• CLINICAL_TRIALS trial_result · 2025-11-21
  Clinical Trial Update: Effect of Immersive Virtual Reality-based Cognitive Remediation in Patients With Mood - or Psychosis Spectrum Disorders [NA]

  A completed clinical trial assessing immersive virtual reality–based cognitive remediation for mood- and psychosis-spectrum disorders.

• CLINICAL_TRIALS research · 2025-02-12
  Clinical Trial Update: The OPUS YOUNG Trial. Early Intervention Versus Treatment as Usual for Adolescents With First-episode Psychosis [NA]

  Clinical trial update for the OPUS YOUNG study comparing early intervention versus treatment as usual for adolescents with first-episode psy…

• CLINICAL_TRIALS trial_result · 2018-04-09
  Clinical Trial Update: A D1 Agonist For Working Memory [Phase 2]

  Phase 2 trial update reporting completion of a study evaluating a D1 dopamine receptor agonist for working memory in individuals with Schizo…

• CLINICAL_TRIALS trial_result · 2017-11-06
  Clinical Trial Update: Exceptional Experiences (EE), Salience & Dopaminergic Neurotransmission [EARLY_Phase 1]

  An early-phase 1 trial completed at the University of Zurich exploring exceptional experiences, salience, and dopaminergic neurotransmission…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2017-08-11
  Clinical Trial Update: Schizotypal Personality Disorder Risperidone [Phase 1, Phase 2]

  Phase 1 and Phase 2 studies evaluating risperidone for schizotypal personality disorder have been completed.

• CLINICAL_TRIALS trial_result · 2017-02-28
  Clinical Trial Update: CRT-Guanfacine for SPD [Phase 2]

  A Phase 2 trial investigating CRT-Guanfacine for Schizotypal Personality Disorder has completed; the update does not include results.

• CLINICAL_TRIALS trial_result · 2017-02-10
  Clinical Trial Update: Pharmacology of Cognition in Schizotypal Personality Disorder [Phase 4]

  Phase 4 clinical trial evaluating pharmacology of cognition in schizotypal personality disorder has been terminated; sponsor is Icahn School…

• CLINICAL_TRIALS research · 2016-08-04
  Clinical Trial Update: Risperidone in the Treatment of Psychotic-like and Deficit Symptoms of Schizotypal Personality Disorder [NA]

  Clinical trial update indicates that a study of risperidone for psychotic-like and deficit symptoms in schizotypal personality disorder has …

• CLINICAL_TRIALS research · 2012-07-20
  Clinical Trial Update: Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality Disorder [Phase 2]

  This report notes a Phase 2 clinical trial testing a D1 dopamine receptor agonist for cognitive enhancement in individuals with schizotypal …